Biocon share news and announcements
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Last close ₹323.50down ₹6.80 (2.06%)BSE ₹326.60
Share price at the NSE close on 23 Oct 2026. Previous close ₹330.30.
52-week range of traded prices to 23 Oct 2026
₹318.40Low, 23 Oct 2026₹447.15High, 16 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹52,721 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 106.4
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 58.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.15%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 34,71,31952.6% delivered
Biocon analyst meets
494 filed, newest first. Page 4 of 10.
Dec 2022
Nov 2022
23 Nov · Analysts
17 Nov · Analysts
17 Nov · Analysts
Oct 2022
Sep 2022
30 Sep · Analysts
29 Sep · Analysts
27 Sep · Analysts
22 Sep · Analysts
20 Sep · Analysts
16 Sep · Analysts
13 Sep · Analysts
Aug 2022
25 Aug · Analysts
24 Aug · Analysts
18 Aug · Analysts
10 Aug · Analysts
Jul 2022
Jun 2022
22 Jun · Analysts
21 Jun · Analysts
15 Jun · Analysts
14 Jun · Analysts
10 Jun · Analysts
10 Jun · Analysts
May 2022
31 May · Analysts
26 May · Analysts
26 May · Analysts
24 May · Analysts
10 May · Analysts
Mar 2022
31 Mar · Analysts
24 Mar · Analysts
10 Mar · Analysts
Feb 2022
17 Feb · Analysts
15 Feb · Analysts
Jan 2022
28 Jan · Analysts
27 Jan · Analysts
Dec 2021
17 Dec · Analysts
13 Dec · Analysts
10 Dec · Analysts